I think it has just got itself in such a tight bind and why the market remains so hesitant. Assuming the standard cash burn of $1.2M a quarter they have 4 months CaB (not attributing todays Undisclosed milestone) and those convertible notes are still standing with the 40% discount which means it is probably going to be incredibly hard for the company to find a reasonable finance option - it's not exactly a mouth watering proposition for anyone to buy on market.
I agree it's good to see Janssen being expanded and reiteration of recent data and "conjugates" slipped in but another 'undisclosed' milestone payment - really ? I still find these things hard to wrap my head around - if the science and recent developments are so ground breaking, why isn't a company the size of Janssen just acquiring the minnow sitting under $10M right now ?
Would of been nice to see Janssen come through with a paragraph praising the science and progress from an external party.
- Forums
- ASX - By Stock
- PYC
- Ann: Janssen Collaboration Expanded
PYC
pyc therapeutics limited
Add to My Watchlist
3.13%
!
$1.40

Ann: Janssen Collaboration Expanded , page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.40 |
Change
-0.045(3.13%) |
Mkt cap ! $813.6M |
Open | High | Low | Value | Volume |
$1.46 | $1.46 | $1.36 | $314.1K | 222.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 330 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 12708 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 330 | 1.395 |
1 | 1225 | 1.390 |
1 | 3000 | 1.350 |
3 | 3254 | 1.340 |
1 | 692 | 1.300 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 12708 | 2 |
1.465 | 22758 | 2 |
1.470 | 16036 | 3 |
1.475 | 20000 | 1 |
1.480 | 2801 | 1 |
Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |